These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 7552513)

  • 21. [Viral load quantification for the early diagnosis of perinatal human immunodeficiency virus 1 (HIV-1) infection].
    Resino García S; Alonso Arias R; Jiménez Fuentes JL; Gurbindo Gutiérrez D; Muñoz-Fernández MA
    An Esp Pediatr; 1998 Jul; 49(1):60-4. PubMed ID: 9718769
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Shifts in cell-associated HIV-1 RNA but not in episomal HIV-1 DNA correlate with new cycles of HIV-1 infection in vivo.
    Fischer M; Trkola A; Joos B; Hafner R; Joller H; Muesing MA; Kaufman DR; Berli E; Hirschel B; Weber R; Günthard HF;
    Antivir Ther; 2003 Apr; 8(2):97-104. PubMed ID: 12741621
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HIV-1 resistant strains acquired at the time of primary infection massively fuel the cellular reservoir and persist for lengthy periods of time.
    Ghosn J; Pellegrin I; Goujard C; Deveau C; Viard JP; Galimand J; Harzic M; Tamalet C; Meyer L; Rouzioux C; Chaix ML;
    AIDS; 2006 Jan; 20(2):159-70. PubMed ID: 16511408
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Temporal dynamics of human T-lymphotropic virus type I tax mRNA and proviral DNA load in peripheral blood mononuclear cells of human T-lymphotropic virus type I-associated myelopathy patients.
    Ramirez E; Cartier L; Torres M; Barria M
    J Med Virol; 2007 Jun; 79(6):782-90. PubMed ID: 17457906
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Measuring viral load in the clinical setting.
    Harrigan R
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995; 10 Suppl 1():S34-40. PubMed ID: 8595506
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Detection of the viral load and its use as a virological marker in the follow-up of HIV-1-positive patients].
    Hodara VL; Monticelli A; Benetucci J; Lasala M; Jauregui Rueda H; Libonatti O; García Messina O; Reboredo G; Bogdanowicz E; Bases O; Pampuro S; Salomón H
    Rev Argent Microbiol; 1998; 30(1):1-7. PubMed ID: 9629601
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CD4 cell count and HIV DNA level are independent predictors of disease progression after primary HIV type 1 infection in untreated patients.
    Goujard C; Bonarek M; Meyer L; Bonnet F; Chaix ML; Deveau C; Sinet M; Galimand J; Delfraissy JF; Venet A; Rouzioux C; Morlat P;
    Clin Infect Dis; 2006 Mar; 42(5):709-15. PubMed ID: 16447119
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Change in plasma viral load, and viral DNA and mRNA burdens, in peripheral blood mononuclear cells from patients infected with HIV-1.
    Fujii T; Kato Y; Takata N; Kimura A
    J Infect; 2001 Jan; 42(1):20-6. PubMed ID: 11243749
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Peripheral blood mononuclear cells of HIV- and HCV-antibody-positive individuals contain HCV RNA but No HCV DNA despite evidence for reverse transcription of HIV RNA into DNA.
    Penning M; Beld M; Goudsmit J
    Virology; 2000 Mar; 268(1):12-6. PubMed ID: 10683322
    [TBL] [Abstract][Full Text] [Related]  

  • 31. One-step nested PCR for detection of 2 LTR circles in PBMCs of HIV-1 infected patients with no detectable plasma HIV RNA.
    Lusi EA; Guarascio P; Presutti C; Villani R; Pellicelli A; Soccorsi F
    J Virol Methods; 2005 Apr; 125(1):11-3. PubMed ID: 15737411
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human immunodeficiency virus type 1 quasi species that rebound after discontinuation of highly active antiretroviral therapy are similar to the viral quasi species present before initiation of therapy.
    Imamichi H; Crandall KA; Natarajan V; Jiang MK; Dewar RL; Berg S; Gaddam A; Bosche M; Metcalf JA; Davey RT; Lane HC
    J Infect Dis; 2001 Jan; 183(1):36-50. PubMed ID: 11106537
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantitative HIV-1 proviral DNA detection: a multicentre analysis.
    De Rossi A; Zanchetta M; Vitone F; Antonelli G; Bagnarelli P; Buonaguro L; Capobianchi MR; Clementi M; Abbate I; Canducci F; Monachetti A; Riva E; Rozera G; Scagnolari C; Tagliamonte M; Re MC;
    New Microbiol; 2010 Oct; 33(4):293-302. PubMed ID: 21213587
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HIV-1 coreceptor usage in paired plasma RNA and proviral DNA from patients with acute and chronic infection never treated with antiretroviral therapy.
    Bon I; Turriziani O; Musumeci G; Clò A; Montagna C; Morini S; Calza L; Gibellini D; Antonelli G; Re MC
    J Med Virol; 2015 Feb; 87(2):315-22. PubMed ID: 25138591
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HIV RNA and HIV DNA in peripheral blood mononuclear cells are consistent markers for estimating viral load in patients undergoing long-term potent treatment.
    Burgard M; Izopet J; Dumon B; Tamalet C; Descamps D; Ruffault A; Vabret A; Bargues G; Mouroux M; Pellegrin I; Ivanoff S; Guisthau O; Calvez V; Seigneurin JM; Rouzioux C
    AIDS Res Hum Retroviruses; 2000 Dec; 16(18):1939-47. PubMed ID: 11153076
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Performance of genotypic tropism testing on proviral DNA in clinical practice: results from the DIVA study group.
    Svicher V; Alteri C; Montano M; D'Arrigo R; Andreoni M; Angarano G; Antinori A; Antonelli G; Allice T; Bagnarelli P; Baldanti F; Bertoli A; Borderi M; Boeri E; Bon I; Bruzzone B; Callegaro AP; Capobianchi MR; Carosi G; Cauda R; Ceccherini-Silberstein F; Clementi M; Chirianni A; Colafigli M; D'Arminio Monforte A; De Luca A; Di Biagio A; Di Nicuolo G; Di Perri G; Di Pietro M; Di Santo F; Fabeni L; Fadda G; Galli M; Gennari W; Ghisetti V; Giacometti A; Gori C; Gori A; Gulminetti R; Leoncini F; Maffongelli G; Maggiolo F; Manca G; Gargiulo F; Martinelli C; Maserati R; Mazzotta F; Meini G; Micheli V; Monno L; Mussini C; Narciso P; Nozza S; Paolucci S; Pal G; Parisi S; Parruti G; Pignataro AR; Pollicita M; Quirino T; Re MC; Rizzardini G; Santangelo R; Scaggiante R; Sterrantino G; Turriziani O; Vatteroni ML; Vecchi L; Viscoli C; Vullo V; Zazzi M; Lazzarini A; Perno CF;
    New Microbiol; 2012 Jan; 35(1):17-25. PubMed ID: 22378549
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of proviral copy number and plasma RNA level as early indicators of progression in HIV-1 infection: correlation with virological and immunological markers of disease.
    Verhofstede C; Reniers S; Van Wanzeele F; Plum J
    AIDS; 1994 Oct; 8(10):1421-7. PubMed ID: 7529507
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of HIV-1 DNA levels as clinical marker of HIV-1-associated nephropathies.
    Izzedine H; Acharya V; Wirden M; Cluzel P; Sene D; Lucas GM; Baumelou A; Atta MG
    Nephrol Dial Transplant; 2011 Feb; 26(2):580-3. PubMed ID: 20624771
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Factors associated with a low HIV reservoir in patients with prolonged suppressive antiretroviral therapy.
    Fourati S; Flandre P; Calin R; Carcelain G; Soulie C; Lambert-Niclot S; Maiga A; Ait-Arkoub Z; Tubiana R; Valantin MA; Autran B; Katlama C; Calvez V; Marcelin AG
    J Antimicrob Chemother; 2014 Mar; 69(3):753-6. PubMed ID: 24187041
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantification of HIV-1 proviral DNA from peripheral blood mononuclear cells using a high throughput four-competitor competitive PCR.
    Comandini UV; Sönnerborg A; Vahlne A; Yun Z
    J Virol Methods; 1997 Dec; 69(1-2):171-80. PubMed ID: 9504762
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.